Corpus ID: 9964002

Hypothermia: role of alpha 1- and alpha 2-noradrenergic receptors in the hypothalamus of the cat.

  title={Hypothermia: role of alpha 1- and alpha 2-noradrenergic receptors in the hypothalamus of the cat.},
  author={Robert D. Myers and Du{\vs}an B. Beleslin and Amir H. Rezvani},
  journal={Pharmacology, biochemistry, and behavior},
  volume={26 2},
The purpose of this study was to characterize the alpha 1- and alpha 2-noradrenergic receptor sub-types which could mediate the hypothermic response produced by norepinephrine (NE) and other alpha-noradrenergic agonists applied to the thermosensitive zone of the hypothalamus. An array of four guide tubes was implanted stereotaxically so that their tips rested just above the anterior hypothalamic, preoptic area (AH/POA) of the cat. Following post-operative recovery, a micro-injection of an… Expand
Preoptic alpha 1- and alpha 2-noradrenergic agonists induce, respectively, PGE2-independent and PGE2-dependent hyperthermic responses in guinea pigs.
Results indicate that alpha(1)- and alpha(2)-AR agonists microdialyzed into the POA of conscious guinea pigs evoke distinct T(c) responses: alpha-1)-AR activation produces quick, PGE(2)independent T( c) rises, and alpha-2-AR stimulation causes an early T(a) fall and a late, COX-2/PGE(2-dependent T(C) rise. Expand
Differential sensitivity to the motor and hypothermic effects of the GABAB receptor agonist baclofen in various mouse strains
It is demonstrated that background strain is an important determinant of GABAB receptor mediated responses, and that hypothermic and ataxic responses may be influenced by independent genetic loci. Expand
Pre- versus postsynaptic signaling by α(2)-adrenoceptors.
This chapter discusses the pre- versus postsynaptic signaling by α 2 -adrenoceptors, and the α 2C -receptor subtype has been shown to inhibit the processing of sensory information in the CNS of the mouse. Expand
Hypothermic responses to infection are inhibited by alpha2-adrenoceptor agonists with possible clinical implications.
Early thermoregulatory responses to infection can be selectively antagonized by ligands that activate alpha(2)-adrenoreceptors, and clinical monitoring using core temperature to detect infection may therefore be unreliable in these vulnerable patients. Expand
Central fatigue and neurotransmitters, can thermoregulation be manipulated?
Dopaminergic reuptake inhibition appears to counteract hyperthermia‐induced fatigue in 30 °C, while noradrenergic neurotransmission shows negative effects on performance in both normal and high temperature, and serotonergic manipulations did not lead to significant changes in performance. Expand
The Involvement of Brain Monoamines in the Onset of Hyperthermic Central Fatigue
The exacerbation of exercise-induced hyperthermia appears to diminish the central nervous system drive to the working muscles; this protects the brain from thermal damage while causing a detriment to physical endurance. Expand
Perioperative Shivering: Physiology and Pharmacology
The organization of the thermoregulatory system, and particularly the physiology of postanesthetic shivering, is reviewed and the pharmacology of thermoreGulation is discussed and the putative mechanisms and sites of action of various antishivering drugs are reviewed. Expand
Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?
Rigorous prospective randomized trials are needed in subsets of patients with a high fever and spiraling toward refractory septic shock and/or presenting with severe ARDS to simplify critical care management when limited cardio-ventilatory reserve is at stake. Expand
Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?
Within the existing guidelines for CCU sedation, this article could facilitate the use of alpha-2 agonists as effective and safe sedation while awaiting large, multicentre trials and more evidence-based medicine. Expand
Antipyretic Effect of Clonidine in Intensive Care Unit Patients: A Nested Observational Study
This report is the first of its kind in humans that demonstrates possible antipyretic properties of enteral clonidine in the critically ill intensive care unit patient. Expand